Dr. Vincent Carson contributes to SMA News Today article on Zolgensma FDA approval

Dr. Vincent Carson, Pediatric Neurologist at the Clinic for Special Children, contributed commentary to a recent SMA News Today article on the FDA approval of Zolgensma, a gene therapy treatment for children with Spinal Muscular Atrophy (SMA).


Click here to read the full article.